These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 10308122)
1. Personal responsibility and the Food and Drug Law. Janssen WF FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122 [No Abstract] [Full Text] [Related]
2. Labeling regulations: 'prescribe as directed'. Regier H J Leg Med (N Y); 1974; 2(5):48-51. PubMed ID: 4548706 [No Abstract] [Full Text] [Related]
3. [The doctor's responsibility and risk in the prescribing of drugs]. Aschenbrenner R Munch Med Wochenschr; 1973 Apr; 115(17):741-6. PubMed ID: 4574431 [No Abstract] [Full Text] [Related]
5. New law broadens FDA safety authority, renews user fees. Fox JL Nat Biotechnol; 2007 Nov; 25(11):1189-90. PubMed ID: 17989653 [No Abstract] [Full Text] [Related]
6. The role of the medical director in the pharmaceutical industry. Lyght CE Curr Ther Res Clin Exp; 1975 Apr; 17(4):408-17. PubMed ID: 804390 [No Abstract] [Full Text] [Related]
7. New York's generic drug substitution law. Kamen A N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574 [No Abstract] [Full Text] [Related]
8. Implications of the Lannett and Pharmadyne decisions. Vetrano AJ Am J Hosp Pharm; 1980 Apr; 37(4):537-40. PubMed ID: 7377217 [TBL] [Abstract][Full Text] [Related]
9. Fifty years of drug amendments revisited: in easy-to-swallow capsule form. Kaplan AH Food Drug Law J; 1995; 50 Spec():179-96. PubMed ID: 10343042 [No Abstract] [Full Text] [Related]
10. Remarks at the Food and Drug Law Institute's 48th Annual Conference. Niedelman SM Food Drug Law J; 2005; 60(2):117-26. PubMed ID: 16097089 [No Abstract] [Full Text] [Related]
11. [Drug problems and the Common Market. Personal views]. Andersen AH Ugeskr Laeger; 1973 Jun; 135(25):1300-1. PubMed ID: 4800706 [No Abstract] [Full Text] [Related]
12. The use of consultants in the parenteral industry. Agalloco JP J Parenter Sci Technol; 1986; 40(6):277-83. PubMed ID: 3819981 [No Abstract] [Full Text] [Related]
13. The Food and Drug Administration and freedom of information. Radzius JR Leg Aspects Med Pract; 1978 Jan; 6(1):52-4. PubMed ID: 750805 [No Abstract] [Full Text] [Related]
14. The parenteral drug industry: recent findings. Fry EM J Parenter Sci Technol; 1982; 36(2):55-8. PubMed ID: 7077464 [No Abstract] [Full Text] [Related]
15. The drug industry and drug effectiveness. Curran WJ N Engl J Med; 1970 Aug; 283(6):304-5. PubMed ID: 5427059 [No Abstract] [Full Text] [Related]
16. Knowledge is power: legislative control of drug industry trade secrets. O'Reilly JT Spec Law Dig Health Care (Mon); 1987 May; 8(15):7-31. PubMed ID: 10281981 [No Abstract] [Full Text] [Related]
17. Drug industry trying to change FDA's slow but sure policy. Demkovich LE Natl J (Wash); 1979 Jul; 11(29):1211-5. PubMed ID: 10242491 [No Abstract] [Full Text] [Related]
20. Medical costs and the drug industry. Schwartz H Wall St J Midwest Ed; 1980 Apr; 60(132):22. PubMed ID: 10245744 [No Abstract] [Full Text] [Related] [Next] [New Search]